Nonprofit · EIN 73-0531256
ENDOCRINE SOCIETY
Tax-exempt · WASHINGTON, DC 20036
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $27,332,119 | $28,871,883 | -$1,539,764 | $81,408,678 | $22,690,002 | $58,718,676 |
| December 31, 2023 | 990 | $28,424,905 | $29,145,077 | -$720,172 | $76,722,016 | $20,928,259 | $55,793,757 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $948,804
- of which government grants
- $169,692
- Program service revenue
- $23,729,088
- Investment income
- $1,817,053
- Royalties
- $351,060
- Net rental income
- $23,231
- Net gain from sales of assets
- -$3,825
- Other revenue
- $837,174
Expenses
- Grants and similar amounts paid
- $235,298
- Compensation of officers, directors and key employees
- $3,012,879
- Other salaries and wages
- $8,616,469
- Salaries, compensation and benefits (total)
- $14,144,544
- Professional fundraising fees
- $0
- Legal fees
- $97,620
- Accounting fees
- $82,948
- Occupancy
- $1,046,490
- Travel
- $1,402,905
- Depreciation
- $807,100
- Program services (functional)
- $17,208,213
- Management and general (functional)
- $10,694,006
- Fundraising (functional)
- $969,664
Balance sheet and other
- Total assets, start of year
- $76,722,016
- Total assets, end of year
- $81,408,678
- Total liabilities, end of year
- $22,690,002
- Net assets, end of year
- $58,718,676
- Land, buildings and equipment
- $10,359,460
- Publicly traded securities
- $57,683,766
- Net assets without donor restrictions
- $52,943,769
- Net assets with donor restrictions
- $5,774,907
- Gross unrelated business income
- $1,362,777
- Gross receipts
- $31,331,098
- Employees
- 89
- Volunteers
- 2,705
- Year formed
- 1918
- State of legal domicile
- DE
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| KATE FRYER | CHIEF EXECUTIVE OFFICER Officer | 37.5 | $721,647 | $73,158 |
| ROB LASH | CHIEF MEDICAL OFFICER Key employee | 37.5 | $401,812 | $66,790 |
| ZERIHUN HAILE-ZELASSIE | CHIEF FINANCIAL OFFICER Officer | 37.5 | $372,589 | $71,848 |
| MILA BECKER | CHIEF POLICY OFFICER Highest-paid employee | 37.5 | $353,656 | $32,497 |
| RICHARD O'GRADY | CHIEF PUBLICATIONS OFFICER Key employee | 37.5 | $305,868 | $66,975 |
| KRISTA KIRK | CHIEF PEOPLE OFFICER Key employee | 37.5 | $295,508 | $66,376 |
| CHRIS URENA | CHIEF LEARNING OFFICER Key employee | 37.5 | $265,173 | $39,537 |
| AARON LOHR | CHIEF COMMUNICATIONS OFFICER Highest-paid employee | 37.5 | $238,804 | $59,884 |
| STEVEN MEYERS | CHIEF STATEGY OFFICER Highest-paid employee | 37.5 | $212,401 | $57,977 |
| MICHAEL FLETCHER | DIRECTOR, IT Highest-paid employee | 37.5 | $176,211 | $54,822 |
| TIMOTHY BEARDSLEY | EXECUTIVE EDITOR Highest-paid employee | 37.5 | $177,976 | $43,620 |
| STEPHEN HAMMES | IMM. PAST PRESIDENT (AS OF 6/24) Trustee or director, Officer | 6 | $37,500 | $0 |
| JOHN NEWELL-PRICE | PRESIDENT (AS OF 6/24) Trustee or director, Officer | 6 | $35,000 | $0 |
| CAROL LANGE | PRESIDENT ELECT (AS OF 6/24) Trustee or director, Officer | 6 | $34,167 | $0 |
| JEFFREY BOORD | SECRETARY-TREASURER Trustee or director, Officer | 6 | $32,500 | $0 |
17 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| KRISTY BROWN | SECR-TREAS. ELECT (AS OF 6/24) Officer | 6 | $6,000 |
| LAUREN FISHBEIN | BOARD MEMBER Trustee or director | 6 | $5,000 |
| STANLEY ANDRISSE | BOARD MEMBER Trustee or director | 6 | $2,292 |
| ANGELA LEUNG | BOARD MEMBER Trustee or director | 6 | $2,000 |
| MARIA FLESERIU | BOARD MEMBER Trustee or director | 6 | $750 |
| REXFORD AHIMA | BOARD MEMBER Trustee or director | 6 | $0 |
| ANDREA GORE | BOARD MEMBER Trustee or director | 6 | $0 |
| KAREN LAM | BOARD MEMBER Trustee or director | 6 | $0 |
| BARBARA ONUMAH | BOARD MEMBER Trustee or director | 6 | $0 |
| RICARDO AZZIZ | BOARD MEMBER Trustee or director | 6 | $0 |
| WILLIAM LEE KRAUS | BOARD MEMBER Trustee or director | 6 | $0 |
| BU YEAP | BOARD MEMBER Trustee or director | 6 | $0 |
| BRUNO FERRAZ DE SOUZA | BOARD MEMBER Trustee or director | 6 | $0 |
| URSULA KAISER | IMM. PAST PRESIDENT (TO 6/24) Trustee or director, Officer | 6 | $0 |
| ARTHUR GUTIERREZ-HARTMANN | BOARD MEMBER (TO 6/24) Trustee or director | 6 | $0 |
| ROCIO PEREIRA | BOARD MEMBER (TO 6/24) Trustee or director | 6 | $0 |
| CAROLYN SMITH | BOARD MEMBER (TO 6/24) Trustee or director | 6 | $0 |
990 for the year ended December 31, 2023: 31 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| KATE FRYER | CHIEF EXECUTIVE OFFICER Officer | 37.5 | $596,950 | $66,660 |
| ROB LASH | CHIEF MEDICAL OFFICER Key employee | 37.5 | $384,588 | $63,455 |
| ZERIHUN HAILE-SELASSIE | CHIEF FINANCIAL OFFICER Officer | 37.5 | $341,327 | $52,577 |
| MILA BECKER | CHIEF POLICY OFFICER Highest-paid employee | 37.5 | $349,988 | $31,314 |
| RICHARD O'GRADY | CHIEF PUBLICATIONS OFFICER Key employee | 37.5 | $306,013 | $62,663 |
| KRISTA KIRK | CHIEF PEOPLE OFFICER Key employee | 37.5 | $278,464 | $60,345 |
| STEVEN MEYERS | CHIEF STATEGY OFFICER Highest-paid employee | 37.5 | $281,205 | $41,417 |
| CHRIS URENA | CHIEF LEARNING OFFICER Key employee | 37.5 | $266,139 | $36,877 |
| AARON LOHR | CHIEF COMMUNICATIONS OFFICER Highest-paid employee | 37.5 | $233,206 | $55,853 |
| MICHAEL FLETCHER | DIRECTOR, IT Highest-paid employee | 37.5 | $177,339 | $50,929 |
| TIMOTHY BEARDSLEY | EXECUTIVE EDITOR Highest-paid employee | 37.5 | $178,984 | $40,418 |
| STEPHEN HAMMES | PRESIDENT Trustee or director, Officer | 6 | $72,500 | $0 |
| JEFFREY BOORD | SECRETARY-TREASURER Trustee or director, Officer | 6 | $60,000 | $0 |
| URSULA KAISER | IMMED. PAST PRESIDENT Trustee or director, Officer | 6 | $55,000 | $0 |
| KAREN LAM | BOARD MEMBER Trustee or director | 6 | $6,474 | $0 |
| MARIA FLESERIU | BOARD MEMBER Trustee or director | 6 | $3,000 | $0 |
| RICHARD AUCHUS | BOARD MEMBER (TO 6/2023) Trustee or director | 6 | $2,500 | $0 |
| CAROLYN WYSHAM | IMMED. PAST PRESIDENT (TO 6/2023) Trustee or director, Officer | 6 | $1,000 | $0 |
| JOHN NEWELL-PRICE | PRESIDENT-ELECT Trustee or director, Officer | 6 | $0 | $0 |
| REXFORD AHIMA | BOARD MEMBER Trustee or director | 6 | $0 | $0 |
| ANDREA GORE | BOARD MEMBER Trustee or director | 6 | $0 | $0 |
| BARBARA ONUMAH | BOARD MEMBER Trustee or director | 6 | $0 | $0 |
| ARTHUR GUTIERREZ-HARTMANN | BOARD MEMBER Trustee or director | 6 | $0 | $0 |
| ROCIO PEREIRA | BOARD MEMBER Trustee or director | 6 | $0 | $0 |
| CAROLYN SMITH | BOARD MEMBER Trustee or director | 6 | $0 | $0 |
| STANLEY ANDRISSE | BOARD MEMBER Trustee or director | 6 | $0 | $0 |
| RICARDO AZZIZ | BOARD MEMBER Trustee or director | 6 | $0 | $0 |
| WILLIAM LEE KRAUS | BOARD MEMBER Trustee or director | 6 | $0 | $0 |
| BU YEAP | BOARD MEMBER Trustee or director | 6 | $0 | $0 |
| RUTH KERI | BOARD MEMBER (TO 6/2023) Trustee or director | 6 | $0 | $0 |
| KATHRYN MARTIN | BOARD MEMBER (TO 6/2023) Trustee or director | 6 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 2055 L ST NW STE 600, WASHINGTON, DC 20036-4988
- Principal officer (990 for 2024)
- KATE FRYER, 2055 L STREET NW NO 600, WASHINGTON, DC 20036
- Signed the 990
- ZERIHUN HAILE-SELASSIE, CHIEF FINANCIAL OFFICER
- Phone
- (202) 971-3636
- Website
- WWW.ENDOCRINE.ORG
- Return prepared by
- CBIZ ADVISORS LLC
Mission
WE UNITE, LEAD, AND GROW THE ENDOCRINE COMMUNITY TO ACCELERATE SCIENTIFIC BREAKTHROUGHS AND IMPROVE HEALTH WORLDWIDE.
Program accomplishments
- EDUCATION, PROGRAMS, AND MEETINGSTHE ENDOCRINE SOCIETY SERVES A ROBUST PORTFOLIO OF PROFESSIONAL, CLINICAL, AND SCIENTIFIC PROGRAMS FOR THE GLOBAL ENDOCRINE COMMUNITY. OUR PRIMARY AUDIENCE IS COMPOSED OF BASIC SCIENTISTS, CLINICIANS, AND PHYSICIAN RESEARCHERS WITHIN THE DISCIPLINE, AS WELL AS PRIMARY/ADVANCED PRACTICE PROVIDERS WHO TREAT AND CARE FOR THOSE WITH ENDOCRINE-RELATED DISEASES AND CONDITIONS. TO THAT END, OUR PORTFOLIO IS BROAD AND DEEP, PLACE-BASED AND DIGITAL, TAILORED TO WORLDWIDE AUDIENCES, AND ANCHORED IN THE LATEST/EMERGING SCIENCE. EACH YEAR WE HOST OUR FLAGSHIP CONFERENCE, ENDO, WHICH ATTRACTS MORE THAN 7000 ATTENDEES FROM AROUND THE GLOBE. THIS SIGNATURE EVENT IS REGARDED AS THE PREMIER SCIENTIFIC EVENT FOR ENDOCRINOLOGISTS AND BOASTS TOP-FLIGHT EDUCATION AND CUTTING-EDGE RESEARCH LED BY 400+ EXPERTS, A BUSTLING EXHIBITION CENTER, AS WELL AS PROFESSIONAL AND SOCIAL NETWORKING EXPERIENCES. ENDO 2025 (SAN FRANCISCO, CALIFORNIA) WAS NO EXCEPTION AND ENDO 2026 IS SET TO DELIVER ANOTHER BANNER PERFORMANCE.A SMALL SAMPLING OF OTHER HIGH-PROFILE PROGRAMS INCLUDE CLINICAL ENDOCRINOLOGY UPDATE (ONLINE CONFERENCE), ENDOCRINE BOARD REVIEW (ONLINE CONFERENCE), ENDOCRINE SELF-ASSESSMENT PROGRAM (PRINT/DIGITAL BOOK), DIMENSIONS IN DIABETES AND ENDOCRINE SUMMIT (IN-PERSON CONFERENCES, MUMBAI, INDIA), AND INTERNATIONAL CONFERENCE ON STEROID HORMONES AND RECEPTOR (ALBUQUERQUE, NEW MEXICO). THE ENDOCRINE SOCIETY CONTINUES TO AMPLIFY AND EXPAND THE EDUCATION PORTFOLIO. FOR A COMPLETE CATALOG OF OUR EDUCATION AND MEETINGS PORTFOLIO, VISIT OUR CENTER FOR LEARNING AT WWW.ENDOCRINE.ORG.Expenses $8,593,131 · revenue $12,185,774
- PUBLICATIONS: ENDOCRINE SOCIETY PUBLICATIONS ENGAGE IN THREE AREAS OF ACTIVITY: JOURNALS, BOOKS, AND CONTENT LICENSING.JOURNALS: THE SOCIETY'S PEER-REVIEWED JOURNALS HAVE BEEN ADVANCING ENDOCRINOLOGY RESEARCH AND CLINICAL CARE FOR MORE THAN A CENTURY, PUBLISHING CONTINUOUSLY SINCE 1917. THE SOCIETY CURRENTLY PUBLISHES FIVE JOURNALS: ENDOCRINOLOGY, ENDOCRINE REVIEWS, THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, JOURNAL OF THE ENDOCRINE SOCIETY, AND JCEM CASE REPORTS. TOGETHER, SOCIETY JOURNALS PUBLISH MORE THAN 1,600 ARTICLES A YEAR FROM SCIENTISTS AND CLINICIANS AROUND THE WORLD, AS WELL AS THE SOCIETY'S OWN CLINICAL PRACTICE GUIDELINES. MORE THAN 2,600 SOCIETY MEMBERS DONATE THEIR TIME EACH YEAR TO THE PEER REVIEW PROCESS. JOURNAL EDITORS AND REVIEWERS ARE VETTED FOR THEIR EXPERTISE AND ADHERENCE TO STRICT PUBLISHING AND RESEARCH INTEGRITY STANDARDS. THE SOCIETY'S JOURNALS FOLLOW THE STANDARDS OF THE INTERNATIONAL COMMITTEE OF MEDICAL JOURNAL EDITORS AND THE COMMITTEE ON PUBLICATION ETHICS.BOOKS: AS PART OF ITS MEDICAL EDUCATION PROGRAM ACCREDITED BY THE ACCREDITATION COUNCIL FOR CONTINUING MEDICAL EDUCATION, THE SOCIETY PUBLISHES BOOKS FOR PHYSICIANS AND HEALTH PROFESSIONALS SEEKING CONTINUING MEDICAL EDUCATION CREDITS, PREPARATION FOR MEDICAL BOARD EXAMS, A BROAD REVIEW OF ALL AREAS OF ENDOCRINOLOGY, AND THE LATEST UPDATES IN THE DIAGNOSIS AND MANAGEMENT OF A WIDE RANGE OF ENDOCRINE CONDITIONS AND DISORDERS.CONTENT LICENSING: THE SOCIETY LICENSES THE DISTRIBUTION RIGHTS FOR ITS JOURNALS, BOOKS, AND OTHER CONTENT INCLUDING CONFERENCE RECORDINGS, PODCASTS, WEBINARS, AND TRANSLATIONS TO PUBLISHERS, INSTITUTIONS, AND MEDICAL EDUCATION COMPANIES WORLDWIDE.Expenses $4,357,213 · revenue $8,906,138
- MEMBERSHIP & ENGAGEMENT:SPANNING 130+ COUNTRIES, ENDOCRINE SOCIETY MEMBERS ARE A GLOBAL COMMUNITY OF 18,000 INVESTIGATORS, SCIENTISTS, HEALTHCARE PROVIDERS, AND EDUCATORS, REPRESENTING ALL CAREER STAGES FROM STUDENTS TO EMERITUS PROFESSORS. DEVOTED TO ADVANCING HORMONE RESEARCH AND EXCELLENCE IN THE CLINICAL PRACTICE OF ENDOCRINOLOGY, THE SOCIETY IS A PREMIER SOURCE OF KNOWLEDGE IN THE ENDOCRINE PROFESSION. MEMBERS BENEFIT FROM EXTENSIVE RESOURCES INCLUDING PUBLICATIONS, EDUCATION, PROFESSIONAL DEVELOPMENT, NETWORKING, AND ADVOCACY EFFORTS AIMED AT ACCELERATING BREAKTHROUGHS AND IMPROVING HEALTH WORLDWIDE.SPECIAL INTEREST GROUP COMMUNITIES ALLOW MEMBERS TO CONNECT WITH FELLOW PROFESSIONALS ON A HOST OF SPECIALTIES AND FIELDS IN ENDOCRINE RESEARCH, CLINICAL CARE AND OTHER SHARED INTERESTS.Expenses $1,249,900 · revenue $2,165,715
- GOVERNMENT AND PUBLIC AFFAIRS: THE ENDOCRINE SOCIETY FOLLOWS POLICY ISSUES IMPORTANT TO THE PROFESSIONAL LIVES OF ITS MEMBERS. THIS INCLUDES ACCESS TO CARE, FUNDING FOR BIOMEDICAL RESEARCH, PREVENTION AND TREATMENT OF DIABETES AND OBESITY, REGULATION OF ENDOCRINE-DISRUPTING CHEMICALS, AND MEDICARE PHYSICIAN PAYMENT. THE SOCIETY REPRESENTS ITS MEMBERS' INTERESTS TO FEDERAL POLICY MAKERS BY PROVIDING EDUCATIONAL INFORMATION, SUBMITTING COMMENTS TO FEDERAL AGENCIES, DEVELOPING POSITION STATEMENTS AND POLICY RECOMMENDATIONS, AND, WITHIN THE LIMITATIONS OF A 501C3, THROUGH DIRECT LOBBYING.THE SOCIETY ALSO REPRESENTS ITS MEMBERS' INTERESTS THROUGH PARTICIPATION WITH OTHER GROUPS AND COALITIONS, SUCH AS THE AMERICAN MEDICAL ASSOCIATION (AMA), THE FEDERATION OF AMERICAN SOCIETIES OF EXPERIMENTAL BIOLOGY (FASEB), AND THE COALITION FOR HEALTH FUNDING.Expenses $1,493,465 · revenue $62,198
- PROFESSIONAL DEVELOPMENT PROGRAMS (EARLY CAREER):. THE ENDOCRINE SOCIETY'S PROFESSIONAL AND CLINICAL AFFAIRS DIVISION CONSISTS OF THREE CORE AREAS: CLINICAL PRACTICE GUIDELINES, PROFESSIONAL DEVELOPMENT, AND PIPELINE DEVELOPMENT PROGRAMS. THROUGH THESE PROGRAMS, THE SOCIETY WORKS TO IMPROVE THE CARE OF PATIENTS WITH ENDOCRINE DISORDERS AND TO SUPPORT THE NEXT GENERATION OF ENDOCRINE CLINICIANS AND SCIENTISTS.CLINICAL PRACTICE GUIDELINE PROGRAMTHE ENDOCRINE SOCIETY PROVIDES THE FIELD OF ENDOCRINOLOGY WITH TIMELY, EVIDENCE-BASED RECOMMENDATIONS FOR CLINICAL CARE AND PRACTICE. OUR CLINICAL PRACTICE GUIDELINES ARE DEVELOPED TO ASSIST HEALTH CARE PROVIDERS, PATIENTS, AND OTHER STAKEHOLDERS IN MAKING INFORMED DECISIONS ABOUT APPROPRIATE HEALTH CARE OPTIONS FOR ENDOCRINE-RELATED CONDITIONS. WE UPDATE OUR GUIDELINES TO REFLECT EVOLVING CLINICAL SCIENCE AND MEET THE NEEDS OF PRACTICING PROVIDERS. OUR GUIDELINES ARE DEVELOPED WITH A COMMITMENT TO THE HIGHEST STANDARDS OF TRUSTWORTHINESS AND TRANSPARENCY AS DEFINED BY THE INSTITUTE OF MEDICINE. GUIDELINE AUTHORS INCLUDE A MULTIDISCIPLINARY PANEL OF EXPERTS, ALONG WITH PATIENT REPRESENTATIVES TO ENSURE THAT RECOMMENDATIONS ARE PATIENT CENTERED. RECENT GUIDELINES PUBLISHED BY THE SOCIETY INCLUDE:-VITAMIN D FOR THE PREVENTION OF DISEASE (2024)-DIAGNOSIS AND THERAPY OF GLUCOCORTICOID-INDUCED ADRENAL INSUFFICIENCY (JOINT WITH THE EUROPEAN SOCIETY OF ENDOCRINOLOGY) (2024)-PRIMARY ALDOSTERONISM (2025)-PRE-EXISTING DIABETES AND PREGNANCY (JOINT WITH THE EUROPEAN SOCIETY OF ENDOCRINOLOGY)PROFESSIONAL DEVELOPMENTIN ADDITION TO PROVIDING CLINICAL GUIDANCE, THE SOCIETY WORKS WITH EARLY CAREER PROFESSIONALS WHO SHOW STRONG POTENTIAL AS FUTURE LEADERS IN ENDOCRINOLOGY, CONNECTING THEM WITH TRAINING, MENTORSHIP, AND PROFESSIONAL DEVELOPMENT. THROUGH THIS WORK, THE SOCIETY PREPARES THE NEXT GENERATION OF ENDOCRINE LEADERS TO ADVANCE SCIENCE AND IMPROVE CARE FOR PEOPLE AFFECTED BY ENDOCRINE CONDITIONS AROUND THE WORLD.-FUTURE LEADERS ADVANCING RESEARCH IN ENDOCRINOLOGY (FLARE) IS A ONE-YEAR PROGRAM THAT PREPARES BASIC SCIENTISTS, CLINICAL RESEARCH TRAINEES, AND JUNIOR FACULTY TO BECOME LEADERS IN ENDOCRINE RESEARCH. PARTICIPANTS BENEFIT FROM A STRUCTURED LEADERSHIP DEVELOPMENT WORKSHOP, HANDS-ON TRAINING IN KEY AREAS SUCH AS GRANTSMANSHIP, STRONG PEER NETWORKS, AND DIRECT MENTORSHIP FROM SENIOR INVESTIGATORS. -EXCELLENCE IN CLINICAL ENDOCRINOLOGY LEADERSHIP (EXCEL) IS A TWO-YEAR PROGRAM THAT PREPARES EARLY CAREER ENDOCRINOLOGISTS TO BECOME LEADERS IN CLINICAL CARE. THE PROGRAM INCLUDES A DEDICATED LEADERSHIP DEVELOPMENT WORKSHOP AND PRACTICAL TRAINING IN AREAS SUCH AS PATIENT CARE, CLINICAL DECISION-MAKING, AND PRACTICE MANAGEMENT. PARTICIPANTS BUILD LASTING PEER CONNECTIONS AND RECEIVE ONE-ON-ONE GUIDANCE FROM EXPERIENCED CLINICAL LEADERS.PIPELINE DEVELOPMENTTO ADDRESS WORKFORCE CHALLENGES, THE ENDOCRINE SOCIETY IS COMMITTED TO THE DEVELOPMENT OF THE NEXT GENERATION OF ENDOCRINE CLINICIANS AND SCIENTISTS. THE UNITED STATES IS FACING A SHORTAGE OF ENDOCRINOLOGISTS AND THE NUMBER OF MEDICAL STUDENTS ENTERING THE FIELD OVER THE PAST TEN YEARS HAS FALLEN. THESE PROGRAMS WORK TO SPARK INTEREST IN ENDOCRINOLOGY AMONG MEDICAL STUDENTS, GRADUATE STUDENTS, AND POSTGRADUATE TRAINEES.-THE SOCIETY'S EARLY CAREER FORUM TARGETS EACH OF THE ABOVE GROUPS. ATTENDEES RECEIVE TRAINING IN AREAS SUCH AS IDENTIFYING CAREER PATHS, APPLYING FOR JOBS, AND DEVELOPING THEIR CVS. EARLY CAREER FORUM PARTICIPANTS ALSO RECEIVE NETWORKING AND EDUCATIONAL OPPORTUNITIES AS ATTENDEES AT THE SOCIETY'S ANNUAL MEETING.-THE RESEARCH EXPERIENCES FOR GRADUATE AND MEDICAL STUDENTS (REGMS) IS A FULL YEAR PROGRAM FOR MEDICAL AND GRADUATE STUDENTS INTERESTED IN PURSUING ENDOCRINE RESEARCH. THIS PROGRAM PROVIDES FUNDING FOR STUDENTS TO CONDUCT RESEARCH WITH AN ENDOCRINE SOCIETY MENTOR. PARTICIPANTS SUBMIT ABSTRACTS THAT ARE HIGHLIGHTED AT SOCIETY'S ANNUAL MEETING.-THE MEDICAL SCHOOL ENGAGEMENT PROGRAM (MSEP) WORKS WITH MEDICAL SCHOOL FACULTY TO INCREASE THEIR STUDENTS' INTEREST IN CAREERS IN ENDOCRINOLOGY. MSEP AIMS TO SPARK AND MAINTAIN INTEREST IN ENDOCRINOLOGY THROUGH INTERACTIVE EVENTS, ACCESS TO ENDOCRINE FACULTY, EXPERIENCES WITH PATIENTS, AND SCHOLARSHIPS TO ATTEND THE SOCIETY'S ANNUAL MEETING.-ENDOCRINE MENTOR DAY (EMD) IS AN IN-PERSON MENTORING AND CAREER DEVELOPMENT EXPERIENCE HELD DURING THE SOCIETY'S ANNUAL MEETING. EMD AIMS TO DEMONSTRATE THE EXCITEMENT AND REWARDS OF A CAREER IN ENDOCRINOLOGY. THE PROGRAM OFFERS MEDICAL STUDENTS AND RESIDENTS A CURATED MEETING EXPERIENCE, INCLUDING ATTENDANCE AT EDUCATIONAL SESSIONS, HANDS-ON TRAINING WITH DIABETES TECHNOLOGY, AND THE OPPORTUNITY TO MEET AND WORK WITH LEADERS IN THE ENDOCRINE COMMUNITY.Expenses $1,514,504 · grants $235,298 · revenue $1,216,154
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 73-0531256
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (509(a)(2))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1942
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Voluntary health associations and medical disciplines (G900)
- Assets (IRS master file)
- $81,408,678
- Income (IRS master file)
- $31,331,098
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $27,332,119 | $28,871,883 | $81,408,678 | XML |
| 990-T | December 2024 | – | – | – | IRS |
| 990 | December 2023 | $28,424,905 | $29,145,077 | $76,722,016 | XML |
| 990-T | December 2023 | – | – | – | IRS |
| 990 | December 2022 | $28,465,926 | $27,971,382 | $75,781,124 | IRS |
| 990-T | December 2022 | – | – | – | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990-T | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990-T | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990 | December 2017 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 73-0531256).
Questions about ENDOCRINE SOCIETY
- What is the EIN of ENDOCRINE SOCIETY?
- The employer identification number (EIN) of ENDOCRINE SOCIETY is 73-0531256.
- Is ENDOCRINE SOCIETY tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1942.
- Are donations to ENDOCRINE SOCIETY tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does ENDOCRINE SOCIETY file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of ENDOCRINE SOCIETY due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did ENDOCRINE SOCIETY last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of ENDOCRINE SOCIETY?
- The 990 for the year ended December 31, 2024 names KATE FRYER.
- Who are the officers and directors of ENDOCRINE SOCIETY?
- The 990 for the year ended December 31, 2024 lists 32 people; 20 received compensation from the organization, the highest $721,647 (KATE FRYER, CHIEF EXECUTIVE OFFICER).
- How much revenue does ENDOCRINE SOCIETY have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $27,332,119, expenses of $28,871,883 and total assets of $81,408,678 at year end.
Other nonprofits in WASHINGTON
- BLOOD CANCER UNITED INC EIN 13-5644916 · last filed 990 for 2025
- AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION EIN 13-5641985 · last filed 990 for 2024
- AMERICAN SOCIETY OF HEMATOLOGY INC EIN 23-7080568 · last filed 990 for 2025
- WHITMAN-WALKER CLINIC INC EIN 52-1122122 · last filed 990 for 2024
- OPTICAL SOCIETY OF AMERICA INC EIN 53-0259696 · last filed 990 for 2024
- AUTISM SPEAKS INC EIN 20-2329938 · last filed 990 for 2025
- FOOD & FRIENDS INC EIN 52-1648941 · last filed 990 for 2025
- MELANOMA RESEARCH ALLIANCE FOUNDATION EIN 26-1636099 · last filed 990 for 2024
All nonprofits in WASHINGTON · District of Columbia · Voluntary health associations and medical disciplines